Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform
SYDNEY, April 15, 2026 /PRNewswire/ — Kazia Therapeutics (NASDAQ: KZIA), a clinical-stage…
Cashco Acquires 3B Controls to Expand its Tank Safety and Storage Portfolio for Chemical, Petrochemical, Biogas and Other High Value Industrial Applications
ELLSWORTH, Kan. and WIDNES, England, April 15, 2026 /PRNewswire/ — Cashco, a…